Refine by
Oncology Equipment Supplied In Belgium
23 equipment items found
Manufactured by:Biocartis NV based inMechelen, BELGIUM
The fully automated Idylla KRAS Mutation Test covers 21 KRAS mutations in exons 2,3 and 4 showing an excellent concordance to reference methods of >95%. Comparison with various other KRAS detecting technologies revealed a superior performance of the IdyllaTM KRAS Mutation Test in terms of ease of use, turnaround time, and hands-on time while demonstrating superior levels of ...
Manufactured by:Biocartis NV based inMechelen, BELGIUM
The fully automated Idylla ctKRAS Mutation Test is minimally invasive, fast and easy to perform and can be used as complement to tissue testing to determine the RAS mutation status at diagnosis. IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC ...
Manufactured by:Biocartis NV based inMechelen, BELGIUM
The fully automated Idylla BRAF Mutation Test covers BRAF V600E, E2, D, K, R and M mutation with a sensitivity of 1% of mutant in wild type background in FFPE samples with an excellent concordance to reference methods of ...
Manufactured by:Biocartis NV based inMechelen, BELGIUM
The fully automated Idylla EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only 1 FFPE tissue section from metastatic NSCLC showing a high concordance of >95% compared with reference ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
Material: Efficast. Thickness: 2 mm. Perforation: Maxi. ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
Material: Efficast. Thickness: 2 mm. Perforation: Maxi. ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
3-points head mask (1.6 mm micro) – nose ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
3-points head mask (1.6 mm micro) – nose, eye and mouth ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
5-points head, neck and shoulders mask with push-pins – different configurations ...
Manufactured by:Orfit Industries NV based inWijnegem, BELGIUM
5-points head, neck and shoulders mask (2 mm maxi) with push-pins – nose ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
The expression of TIM reduces signaling of the TCR complex by interfering with the CD3ζ component of the TCR complex. Celyad Oncology plans to initiate the KEYNOTE-B79 trial to evaluate CYAD-101 with Merck’s anti-PD1 therapy, KEYTRUDA (pembrolizumab), in refractory mCRC patients with microsatellite stable / mismatch-repair proficient disease during the fourth ...
Manufactured by:eTheRNA based inNiel, BELGIUM
Therapeutic area: immuno-oncology; Intra-tumoral (IT) ...
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
Colli-Pee® 20 mL allows for standardized and volumetric urine collection of the first 20mL of urine flow. This has applications in infectious diseases and oncology. Collector tubes can be pre-filled with a preservative for different urinary analytes, improving transport and storage of urine at room ...
Manufactured by:Precirix based inBrussels, BELGIUM
This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such as breast and gastric adenocarcinoma. In addition to the company’s lead program, two product candidates for undisclosed oncology targets are entering IND-enabling initiatives. PRECIRIX’ preclinical programs further focus on the ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
CYAD-221 is a preclinical short hairpin RNA (shRNA)-based allogeneic CAR T candidate for the treatment of B-cell malignancies. CYAD-221 is engineered to co-express a CD19 chimeric antigen receptor and an shRNA hairpin which interferes with the expression of the CD3ζ component of the TCR ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
CYAD-02 is an investigational CAR T therapy that engineers an all-in-one vector approach in patient’s T cells to express both (i) the NKG2D chimeric antigen receptor, a receptor expressed on natural killer (NK) cells that binds to eight stress-induced ligands (NKG2DL) expressed on tumor cells, and (ii) short hairpin RNA (shRNA) technology to knockdown the expression of NKG2D ligands MICA ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
CYAD-231 is a dual specific CAR T candidate targeting NKG2D and an undisclosed membrane protein. The short hairpin RNA (shRNA)-based allogeneic CAR T candidate is in preclinical ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
CYAD-211 is a short hairpin RNA (shRNA)-based allogeneic CAR T candidate for the treatment of relapsed or refractory multiple myeloma (r/r MM). CYAD-211 is engineered to co-express a B-cell maturation antigen (BCMA) chimeric antigen receptor and a single shRNA hairpin which interferes with the expression of the CD3ζ component of the TCR complex. CYAD-211 is currently being evaluated, ...
Manufactured by:Celyad Oncology based inMont-Saint-Guibert, BELGIUM
CYAD-203 is a preclinical, non-gene edited allogeneic CAR T candidate and our first armored CAR T candidate engineered to co-express the cytokine interleukin-18 (IL-18) with the NKG2D CAR receptor. IL-18 is a proinflammatory cytokine that directly potentiates the anti-cancer activity of CAR T cells while also altering the balance of pro- and anti-inflammatory cells within tumor tissue. CYAD-203 ...
Manufactured by:LinaTech based inShanghai, CHINA
The TiGRT Treatment Planning System (TPS) offers 3D conformal RT, Step-and-Shoot IMRT, Dynamic Sliding IMRT, ARC Optimization IMRT by using modified Generic Algorithms.* Auto Beam Selection and Aperture Based Optimization features are also included. TiGRT TPS makes radiation treatment planning and communications simple, easy and seamless for the dosimetrist, physicist and radiation oncologist. * ...